duncs500 wrote: Mon Aug 11, 2025 12:27 pm
Jobbo is of course correct re fees. I've been with HL for a long time and have no idea of they're still competitive on fees TBH. I only use for funds these days FWIW, but I'm sure they're not even in that case.
My ReSEarch suggests that the fees seem to vary quite a bit from ETF to ETF. Buying shares through HL seems far more spenny than through T212, unless you are buying big numbers in one go.
I've managed 18% growth over the last month on my shares in Oxford Nanopore, as ever wishing I had bought sooner and more.
The unfortunate side effect is that it has caused me to optimistically have a go at a few other biotechs which have done far less well (as in +/- 1% over a month ... still that's no great loss).